Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in in Toronto, Canada.
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorFinance
SymbolNASDAQ:CRON
CUSIPN/A
Phone416-504-0004
Debt
Debt-to-Equity Ratio0.04
Current Ratio20.68
Quick Ratio15.92
Price-To-Earnings
Trailing P/E Ratio724.00
Forward P/E Ratio-724.00
P/E GrowthN/A
Sales & Book Value
Annual Sales$3.15 million
Price / Sales404.98
Cash Flow$0.0188 per share
Price / Cash384.17
Book Value$0.47 per share
Price / Book15.40
Profitability
EPS (Most Recent Fiscal Year)$0.01
Net Income$1.92 million
Net Margins35.12%
Return on Equity2.74%
Return on Assets2.45%
Miscellaneous
Employees74
Outstanding Shares176,200,000
Cronos Group (NASDAQ:CRON) Frequently Asked Questions
What is Cronos Group's stock symbol?
Cronos Group trades on the NASDAQ under the ticker symbol "CRON."
How were Cronos Group's earnings last quarter?
Cronos Group Inc (NASDAQ:CRON) announced its quarterly earnings data on Monday, April, 30th. The company reported $0.01 EPS for the quarter. The firm had revenue of $1.27 million for the quarter. Cronos Group had a net margin of 35.12% and a return on equity of 2.74%. View Cronos Group's Earnings History.
When is Cronos Group's next earnings date?
Are investors shorting Cronos Group?
Cronos Group saw a increase in short interest in May. As of May 31st, there was short interest totalling 12,489,037 shares, an increase of 35.0% from the May 15th total of 9,251,837 shares. Based on an average daily volume of 2,512,441 shares, the short-interest ratio is presently 5.0 days. View Cronos Group's Current Options Chain.
Who are some of Cronos Group's key competitors?
Some companies that are related to Cronos Group include Melco International Development (MDEVF), Eutelsat Communications (EUTLF), BROTHER INDUSTR/ADR (BRTHY), Kawasaki Heavy Industries (KWHIY), HITACHI Chem Co/ADR (HCHMY), KONICA MINOLTA/ADR (KNCAY), Renishaw (RNSHF), Saipem (SAPMF), Mediaset Espana (GETVY), Hikma Pharmaceuticals (HKMPF), SPECTRIS PLC/ADR (SEPJY), Derwent London (DWVYF), Dainippon Screen (DINRF), Orion (ORINY) and Howdens Joinery (HWDJY).
Who are Cronos Group's key executives?
Cronos Group's management team includes the folowing people:
- Mr. Michael Gorenstein, Chairman, CEO, Pres & Corp. Sec.
- Mr. William Hilson, Chief Financial Officer
- Mr. David Hsu, Chief Operating Officer
- Ms. Xiuming Shum, Gen. Counsel
- Mr. Kevin B Gifford, VP of Fin. & Corp. Devel.
Has Cronos Group been receiving favorable news coverage?
Media stories about CRON stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cronos Group earned a news sentiment score of 0.11 on Accern's scale. They also gave media stories about the company an impact score of 48.19 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
Who are Cronos Group's major shareholders?
Cronos Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (1.23%), JW Asset Management LLC (0.63%), Fiera Capital Corp (0.03%), Commonwealth Equity Services LLC (0.02%), Polar Asset Management Partners Inc. (0.02%) and Royal Bank of Canada (0.01%). View Institutional Ownership Trends for Cronos Group.
Which institutional investors are buying Cronos Group stock?
CRON stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, JW Asset Management LLC, Fiera Capital Corp, Commonwealth Equity Services LLC, Polar Asset Management Partners Inc. and Royal Bank of Canada. View Insider Buying and Selling for Cronos Group.
How do I buy shares of Cronos Group?
Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cronos Group's stock price today?
One share of CRON stock can currently be purchased for approximately $7.24.
How big of a company is Cronos Group?
Cronos Group has a market capitalization of $1.27 billion and generates $3.15 million in revenue each year. The company earns $1.92 million in net income (profit) each year or $0.01 on an earnings per share basis. Cronos Group employs 74 workers across the globe.
How can I contact Cronos Group?
Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 416-504-0004.
MarketBeat Community Rating for Cronos Group (CRON)
MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.
